Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis

OBJECTIVE: To analyze major histocompatibility complex expression in the muscle fibers of juvenile and adult dermatomyositis. METHOD: In total, 28 untreated adult dermatomyositis patients, 28 juvenile dermatomyositis patients (Bohan and Peter's criteria) and a control group consisting of four dystrophic and five Pompe's disease patients were analyzed. Routine histological and immunohistochemical (major histocompatibility complex I and II, StreptoABComplex/HRP, Dakopatts) analyses were performed on serial frozen muscle sections. Inflammatory cells, fiber damage, perifascicular atrophy and increased connective tissue were analyzed relative to the expression of major histocompatibility complexes I and II, which were assessed as negatively or positively stained fibers in 10 fields (200X). RESULTS: The mean ages at disease onset were 42.0±15.9 and 7.3±3.4 years in adult and juvenile dermatomyositis, respectively, and the symptom durations before muscle biopsy were similar in both groups. No significant differences were observed regarding gender, ethnicity and frequency of organ involvement, except for higher creatine kinase and lactate dehydrogenase levels in adult dermatomyositis (p<0.050). Moreover, a significantly higher frequency of major histocompatibility complex I (96.4% vs. 50.0%, p<0.001) compared with major histocompatibility complex II expression (14.3% vs. 53.6%, p=0.004) was observed in juvenile dermatomyositis. Fiber damage (p=0.006) and increased connective tissue (p<0.001) were significantly higher in adult dermatomyositis compared with the presence of perifascicular atrophy (p<0.001). The results of the histochemical and histological data did not correlate with the demographic data or with the clinical and laboratory features. CONCLUSION: The overexpression of major histocompatibility complex I was an important finding for the diagnosis of both groups, particularly for juvenile dermatomyositis, whereas there was lower levels of expression of major histocompatibility complex II than major histocompatibility complex I. This finding was particularly apparent in juvenile dermatomyositis.

Saved in:
Bibliographic Details
Main Authors: Shinjo,Samuel Katsuyuki, Sallum,Adriana Maluf Elias, Silva,Clovis Artur, Marie,Suely Kazue Nagahashi
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2012
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800005
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322012000800005
record_format ojs
spelling oai:scielo:S1807-593220120008000052012-08-30Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositisShinjo,Samuel KatsuyukiSallum,Adriana Maluf EliasSilva,Clovis ArturMarie,Suely Kazue Nagahashi Adult Dermatomyositis Idiopathic Inflammatory Myopathies Juvenile Dermatomyositis Major Histocompatibility Complex Muscle Biopsy OBJECTIVE: To analyze major histocompatibility complex expression in the muscle fibers of juvenile and adult dermatomyositis. METHOD: In total, 28 untreated adult dermatomyositis patients, 28 juvenile dermatomyositis patients (Bohan and Peter's criteria) and a control group consisting of four dystrophic and five Pompe's disease patients were analyzed. Routine histological and immunohistochemical (major histocompatibility complex I and II, StreptoABComplex/HRP, Dakopatts) analyses were performed on serial frozen muscle sections. Inflammatory cells, fiber damage, perifascicular atrophy and increased connective tissue were analyzed relative to the expression of major histocompatibility complexes I and II, which were assessed as negatively or positively stained fibers in 10 fields (200X). RESULTS: The mean ages at disease onset were 42.0±15.9 and 7.3±3.4 years in adult and juvenile dermatomyositis, respectively, and the symptom durations before muscle biopsy were similar in both groups. No significant differences were observed regarding gender, ethnicity and frequency of organ involvement, except for higher creatine kinase and lactate dehydrogenase levels in adult dermatomyositis (p<0.050). Moreover, a significantly higher frequency of major histocompatibility complex I (96.4% vs. 50.0%, p<0.001) compared with major histocompatibility complex II expression (14.3% vs. 53.6%, p=0.004) was observed in juvenile dermatomyositis. Fiber damage (p=0.006) and increased connective tissue (p<0.001) were significantly higher in adult dermatomyositis compared with the presence of perifascicular atrophy (p<0.001). The results of the histochemical and histological data did not correlate with the demographic data or with the clinical and laboratory features. CONCLUSION: The overexpression of major histocompatibility complex I was an important finding for the diagnosis of both groups, particularly for juvenile dermatomyositis, whereas there was lower levels of expression of major histocompatibility complex II than major histocompatibility complex I. This finding was particularly apparent in juvenile dermatomyositis.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.67 n.8 20122012-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800005en10.6061/clinics/2012(08)05
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Shinjo,Samuel Katsuyuki
Sallum,Adriana Maluf Elias
Silva,Clovis Artur
Marie,Suely Kazue Nagahashi
spellingShingle Shinjo,Samuel Katsuyuki
Sallum,Adriana Maluf Elias
Silva,Clovis Artur
Marie,Suely Kazue Nagahashi
Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis
author_facet Shinjo,Samuel Katsuyuki
Sallum,Adriana Maluf Elias
Silva,Clovis Artur
Marie,Suely Kazue Nagahashi
author_sort Shinjo,Samuel Katsuyuki
title Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis
title_short Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis
title_full Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis
title_fullStr Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis
title_full_unstemmed Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis
title_sort skeletal muscle major histocompatibility complex class i and ii expression differences in adult and juvenile dermatomyositis
description OBJECTIVE: To analyze major histocompatibility complex expression in the muscle fibers of juvenile and adult dermatomyositis. METHOD: In total, 28 untreated adult dermatomyositis patients, 28 juvenile dermatomyositis patients (Bohan and Peter's criteria) and a control group consisting of four dystrophic and five Pompe's disease patients were analyzed. Routine histological and immunohistochemical (major histocompatibility complex I and II, StreptoABComplex/HRP, Dakopatts) analyses were performed on serial frozen muscle sections. Inflammatory cells, fiber damage, perifascicular atrophy and increased connective tissue were analyzed relative to the expression of major histocompatibility complexes I and II, which were assessed as negatively or positively stained fibers in 10 fields (200X). RESULTS: The mean ages at disease onset were 42.0±15.9 and 7.3±3.4 years in adult and juvenile dermatomyositis, respectively, and the symptom durations before muscle biopsy were similar in both groups. No significant differences were observed regarding gender, ethnicity and frequency of organ involvement, except for higher creatine kinase and lactate dehydrogenase levels in adult dermatomyositis (p<0.050). Moreover, a significantly higher frequency of major histocompatibility complex I (96.4% vs. 50.0%, p<0.001) compared with major histocompatibility complex II expression (14.3% vs. 53.6%, p=0.004) was observed in juvenile dermatomyositis. Fiber damage (p=0.006) and increased connective tissue (p<0.001) were significantly higher in adult dermatomyositis compared with the presence of perifascicular atrophy (p<0.001). The results of the histochemical and histological data did not correlate with the demographic data or with the clinical and laboratory features. CONCLUSION: The overexpression of major histocompatibility complex I was an important finding for the diagnosis of both groups, particularly for juvenile dermatomyositis, whereas there was lower levels of expression of major histocompatibility complex II than major histocompatibility complex I. This finding was particularly apparent in juvenile dermatomyositis.
publisher Faculdade de Medicina / USP
publishDate 2012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800005
work_keys_str_mv AT shinjosamuelkatsuyuki skeletalmusclemajorhistocompatibilitycomplexclassiandiiexpressiondifferencesinadultandjuveniledermatomyositis
AT sallumadrianamalufelias skeletalmusclemajorhistocompatibilitycomplexclassiandiiexpressiondifferencesinadultandjuveniledermatomyositis
AT silvaclovisartur skeletalmusclemajorhistocompatibilitycomplexclassiandiiexpressiondifferencesinadultandjuveniledermatomyositis
AT mariesuelykazuenagahashi skeletalmusclemajorhistocompatibilitycomplexclassiandiiexpressiondifferencesinadultandjuveniledermatomyositis
_version_ 1756432168243953664